300149 Stock Overview
Chempartner Pharmatech Co., Ltd. engages in the microecological nutrition and healthcare businesses worldwide.
Snowflake Score | |
---|---|
Valuation | 2/6 |
Future Growth | 0/6 |
Past Performance | 0/6 |
Financial Health | 5/6 |
Dividends | 0/6 |
ChemPartner PharmaTech Co.,Ltd. Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | CN¥5.58 |
52 Week High | CN¥9.74 |
52 Week Low | CN¥3.68 |
Beta | 0.64 |
1 Month Change | -1.41% |
3 Month Change | 29.47% |
1 Year Change | -32.28% |
3 Year Change | -63.91% |
5 Year Change | -63.34% |
Change since IPO | -17.11% |
Recent News & Updates
Shareholder Returns
300149 | CN Biotechs | CN Market | |
---|---|---|---|
7D | 5.9% | 5.2% | 2.2% |
1Y | -32.3% | -12.9% | -10.2% |
Return vs Industry: 300149 underperformed the CN Biotechs industry which returned -13.7% over the past year.
Return vs Market: 300149 underperformed the CN Market which returned -11.3% over the past year.
Price Volatility
300149 volatility | |
---|---|
300149 Average Weekly Movement | 9.6% |
Biotechs Industry Average Movement | 6.7% |
Market Average Movement | 7.4% |
10% most volatile stocks in CN Market | 11.0% |
10% least volatile stocks in CN Market | 4.3% |
Stable Share Price: 300149's share price has been volatile over the past 3 months.
Volatility Over Time: 300149's weekly volatility (10%) has been stable over the past year, but is still higher than 75% of CN stocks.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
2000 | 2,072 | Swee Woo | www.cppt.com.cn |
Chempartner Pharmatech Co., Ltd. engages in the microecological nutrition and healthcare businesses worldwide. The company operates in two segments, Microecological Nutrition and Medical Business; and Pharmaceutical Research and Development Service and Production Outsourcing Business. It offers prebiotic products and the provision of microecological medical services.
ChemPartner PharmaTech Co.,Ltd. Fundamentals Summary
300149 fundamental statistics | |
---|---|
Market cap | CN¥2.78b |
Earnings (TTM) | -CN¥907.94m |
Revenue (TTM) | CN¥1.14b |
2.4x
P/S Ratio-3.1x
P/E RatioIs 300149 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
300149 income statement (TTM) | |
---|---|
Revenue | CN¥1.14b |
Cost of Revenue | CN¥856.34m |
Gross Profit | CN¥282.03m |
Other Expenses | CN¥1.19b |
Earnings | -CN¥907.94m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
n/a
Earnings per share (EPS) | -1.82 |
Gross Margin | 24.77% |
Net Profit Margin | -79.76% |
Debt/Equity Ratio | 12.0% |
How did 300149 perform over the long term?
See historical performance and comparison